Analyst firms · Wolfe Research · ARGX
Wolfe Research ARGX price target and rating history
argenx SE (ARGX) · Health Care
Wolfe Research rates argenx SE (ARGX) Peer Perform with a $697 price target, as of its latest action on Nov 24, 2025. It has published 4 rating actions on ARGX since July 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.
- Current rating
- Peer Perform
- Price target
- $697
- Median target, all firms
- $1,185
- Actions on ARGX
- 4
Every Wolfe Research rating on ARGX
- Nov 24, 2025
- Nov 12, 2024
- Feb 15, 2024
- Jul 19, 2021
How other firms rate ARGX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $1,400 | Aug 26, 2026 |
| Deutsche Bank | Hold | Aug 24, 2026 | |
| Guggenheim | Buy | $1,185 | Aug 4, 2026 |
| Robert W. Baird | Neutral | $858 | Dec 18, 2025 |
| Wolfe Research | Peer Perform | Nov 24, 2025 |
Questions about Wolfe Research and ARGX
- What is Wolfe Research's price target for ARGX?
- Wolfe Research's latest stated price target for argenx SE (ARGX) is $697, from its action on Nov 12, 2024.
- What is Wolfe Research's rating on ARGX?
- Wolfe Research rates ARGX Peer Perform, a neutral rating, as of Nov 24, 2025.
- When did Wolfe Research last change its view on ARGX?
- On Nov 24, 2025, Wolfe Research downgrades to Peer Perform from Outperform.
- How does Wolfe Research's ARGX target compare with other analysts?
- Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.
More ARGX rating histories
All Wolfe Research ratingsARGX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.